Discovery of KT-413, a Targeted Protein Degrader of IRAK4 and IMiD Substrates Targeting MYD88 Mutant Diffuse Large B-Cell Lymphoma
Weiss, M.M., Zheng, X., Ji, N., Browne, C.M., Campbell, V., Chen, D., Enerson, B., Fei, X., Huang, X., Klaus, C.R., Li, H., Mayo, M., McDonald, A.A., Paul, A., Rong, H., Sharma, K., Shi, Y., Slavin, A., Walther, D.M., Yuan, K., Zhang, Y., Zhu, X., Kelleher, J., Walker, D., Mainolfi, N.(2024) J Med Chem